Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-11-29 5:08 pm Purchase | 13D | SPYRE THERAPEUTICS, INC SYRE | Fairmount Funds Management LLC | 3,813,901 12.7% | 3,813,901 (New Position) | View |
| 2023-11-03 4:30 pm Purchase | 13D | VIRIDIAN THERAPEUTICS INC VRDN | Fairmount Funds Management LLC | 12,764,393 19.99% | 3,571,579 (+38.85%) | View |
| 2023-10-10 4:30 pm Purchase | 13G | SOLENO THERAPEUTICS INC PA SLNO | Fairmount Funds Management LLC | 950,000 6.2% | 950,000 (New Position) | View |
| 2023-09-21 4:32 pm Purchase | 13D | DIANTHUS THERAPEUTICS INC DNTH | Fairmount Funds Management LLC | 1,873,833 12.7% | 1,873,833 (New Position) | View |
| 2023-08-10 4:15 pm Purchase | 13G | KINIKSA PHARMACEUTICALS LTD KNSA | Fairmount Funds Management LLC | 2,143,052 6.1% | 2,143,052 (New Position) | View |
| 2023-07-21 4:31 pm Purchase | 13D | APOGEE THERAPEUTICS INC APGE | Fairmount Funds Management LLC | 3,906,202 9.99% | 3,906,202 (New Position) | View |
| 2023-07-07 4:00 pm Purchase | 13G | AXSOME THERAPEUTICS INC AXSM | Fairmount Funds Management LLC | 2,344,980 5% | 333,333 (+16.57%) | View |
| 2023-06-30 5:24 pm Purchase | 13D | AEGLEA BIOTHERAPEUTICS, INC. C AGLE | Fairmount Funds Management LLC | 19,590,000 19.99% | 19,590,000 (New Position) | View |
| 2023-06-13 4:06 pm Purchase | 13D | COGENT BIOSCIENCES INC COGT | Fairmount Funds Management LLC | 19,962,564 19.99% | 4,732,091 (+31.07%) | View |
| 2023-04-27 10:00 am Purchase | 13G | ENLIVEN THERAPEUTICS INC ELVN | Fairmount Funds Management LLC | 2,124,625 5.17% | 2,124,625 (New Position) | View |
| 2023-02-14 3:45 pm Purchase | 13G | ANNEXON INC ANNX | Fairmount Funds Management LLC | 3,681,456 7.7% | 1,112,056 (+43.28%) | View |
| 2023-02-14 3:45 pm Sale | 13G | AXSOME THERAPEUTICS INC AXSM | Fairmount Funds Management LLC | 2,011,647 4.6% | -155,000 (-7.15%) | View |
| 2023-02-14 3:45 pm Purchase | 13G | ASTRIA THERAPEUTICS INC ATXS | Fairmount Funds Management LLC | 1,901,397 6.9% | 989,661 (+108.55%) | View |
| 2023-02-14 3:45 pm Sale | 13G | OLEMA PHARMACEUTICALS INC OLMA | Fairmount Funds Management LLC | 0 0% | -2,107,873 (Position Closed) | View |
| 2023-02-14 3:45 pm Purchase | 13G | NUVALENT INC NUVL | Fairmount Funds Management LLC | 2,788,981 5.47% | 183,857 (+7.06%) | View |
| 2023-02-14 3:45 pm Purchase | 13G | TERNS PHARMACEUTICALS INC TERN | Fairmount Funds Management LLC | 5,269,287 9.9% | 3,219,287 (+157.04%) | View |
| 2023-02-14 3:45 pm Purchase | 13G | TREVI THERAPEUTICS INC TRVI | Fairmount Funds Management LLC | 6,018,465 9.9% | 2,258,955 (+60.09%) | View |
| 2022-11-09 10:02 am Purchase | 13G | NUVALENT INC NUVL | Fairmount Funds Management LLC | 2,605,124 5.13% | 2,605,124 (New Position) | View |
| 2022-10-25 9:09 pm Purchase | 13G | AXSOME THERAPEUTICS INC AXSM | Fairmount Funds Management LLC | 2,166,647 5.4% | 2,166,647 (New Position) | View |
| 2022-08-25 09:32 am Purchase | 13G | TERNS PHARMACEUTICALS INC TERN | Fairmount Funds Management LLC | 2,050,000 5.45% | 2,050,000 (New Position) | View |